GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (BUE:AZN) » Definitions » Gross Profit

AstraZeneca (BUE:AZN) Gross Profit : ARS31,917,013 Mil (TTM As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is AstraZeneca Gross Profit?

AstraZeneca's gross profit for the three months ended in Sep. 2024 was ARS9,965,042 Mil. AstraZeneca's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was ARS31,917,013 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. AstraZeneca's gross profit for the three months ended in Sep. 2024 was ARS9,965,042 Mil. AstraZeneca's Revenue for the three months ended in Sep. 2024 was ARS12,893,532 Mil. Therefore, AstraZeneca's Gross Margin % for the quarter that ended in Sep. 2024 was 77.29%.

AstraZeneca had a gross margin of 77.29% for the quarter that ended in Sep. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of AstraZeneca was 82.06%. The lowest was 66.76%. And the median was 79.96%.


AstraZeneca Gross Profit Historical Data

The historical data trend for AstraZeneca's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Gross Profit Chart

AstraZeneca Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,163,373.57 1,734,858.78 2,522,730.15 5,358,093.85 13,553,023.01

AstraZeneca Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,288,480.24 3,507,476.00 8,813,392.65 9,631,102.36 9,965,041.56

Competitive Comparison of AstraZeneca's Gross Profit

For the Drug Manufacturers - General subindustry, AstraZeneca's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AstraZeneca's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's Gross Profit distribution charts can be found below:

* The bar in red indicates where AstraZeneca's Gross Profit falls into.



AstraZeneca Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

AstraZeneca's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=16537771.015 - 2984748.003
=13,553,023

AstraZeneca's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=12893531.933 - 2928490.371
=9,965,042

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ARS31,917,013 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

AstraZeneca's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=9,965,042 / 12893531.933
=77.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


AstraZeneca  (BUE:AZN) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

AstraZeneca had a gross margin of 77.29% for the quarter that ended in Sep. 2024 => Durable competitive advantage


AstraZeneca Gross Profit Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


AstraZeneca Business Description

Address
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.